Clinical Trials Directory

Trials / Unknown

UnknownNCT04127422

Risk Factors for Benign Breast Disease

Risk Factors for Benign Breast Disease in Young Adult Women. Case-control Study

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
Female
Age
18 Years – 39 Years
Healthy volunteers
Accepted

Summary

Benign diseases of the breast are common clinical conditions that affect young women. Complaints related to the breast often cause significant discomfort and mental stress. The following study will try to identify the risk factors that may be associated with symptomatic benign breast diseases. Identification of such factors may help preventing and / or treating these conditions.

Detailed description

Benign breast disease (BBD) is a common cause of hospital visit. In young adults, benign breast conditions surpass cancer as a cause of symptoms related to the breast. However, breast symptoms may be associated with significant distress and may impose diagnostic difficulties. Moreover, certain pathological entities of benign breast conditions are well known to increase the risk of breast cancer. Identification of modifiable risk factors associated with symptomatic breast disorders has several potential benefits. Modification of such factors may help decrease patients' distress, hospital visits and indirectly decrease the risk of cancer. the available data point to the possible association of several environmental factors with symptomatic BBD. Most of the available information points to an association of BBD with anthropometric features, growth pattern, family history of breast conditions and dietary consumption. Substantial evidence are however lacking and further studies are strongly required to better characterize the risk factors of the condition. In this study, the investigators will systematically collect epidemiological, developmental and clinical data in young patients presenting with breast complaints. The association with disease incidence, pattern and histology will be examined.

Conditions

Timeline

Start date
2019-11-28
Primary completion
2021-02-01
Completion
2021-04-01
First posted
2019-10-15
Last updated
2020-11-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04127422. Inclusion in this directory is not an endorsement.